We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Hand-Held Lab-On-A-Chip Diagnoses HIV

By LabMedica International staff writers
Posted on 09 Aug 2011
A hand-held lab-on-a-chip diagnoses infectious diseases such as Human immunosuppressive virus (HIV) and syphilis at patients' bedsides.

Named the mChip (from mobile microfluidic chip), the integrated microfluidic-based diagnostic device—a lab-on-a-chip—can perform complex laboratory assays, and do so with such simplicity that these tests can be carried out in the most remote regions of the world.

Prof. More...
Samuel K. Sia's lab at Columbia Engineering (New York, NY, USA) developed the mChip devices in collaboration with Claros Diagnostics Inc. (Woburn, MA, USA), a venture capital-backed startup that Sia cofounded in 2004. The cost of the chip is about US$1 and the entire instrument about $100.

In a paper published online in Nature Medicine on July 31, 2011, Prof. Sia and his colleagues presented field results on how microfluidics and nanoparticles could be successfully leveraged to produce a functional low-cost diagnostic device in extreme resource-limited settings. The authors wrote, "The chip had excellent performance in the diagnosis of HIV using only 1 μL of unprocessed whole blood and an ability to simultaneously diagnose HIV and syphilis with sensitivities and specificities that rival those of reference benchtop assays"

Prof. Sia and his team performed the testing in Rwanda during four years in partnership with Columbia's Mailman School of Public Health (New York, NY, USA) and three local nongovernmental organizations in Rwanda, targeting hundreds of patients.

"We have engineered a disposable credit card-sized device that can produce blood-based diagnostic results in minutes," said Prof. Sia. "The idea is to make a large class of diagnostic tests accessible to patients in any setting in the world, rather than forcing them to go to a clinic to draw blood and then wait days for their results."

The device allows blood checks for deadly infectious diseases that could benefit newborns and pregnant women especially in pockets where diagnostic tests are either not possible or not reachable. Results can be seen with the naked eye or with a low-cost detector.

Named one of the world's top young innovators for 2010 by MIT's Technology Review for his work in biotechnology and medicine, and by NASA as one of 10 innovators in human health and sustainability, Prof. Sia also received a Career award in 2008 from the National Science Foundation.

Related Links:
Columbia Engineering
Claros Diagnostics Inc.
Columbia's Mailman School of Public Health




New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Biochemical Analyzer
iBC 900
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: A diagnostic test can distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone (Photo courtesy of University of Turku)

Novel Diagnostic Tool to Revolutionize Treatment Guidance of Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a solid tumor type commonly treated with surgery. However, there has been no clinically available method to determine which patients can be cured with surgery... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: The smart microscope can predict the onset of misfolded protein aggregation, a hallmark of neurodegenerative diseases (Photo courtesy of EPFL)

Self-Driving Microscope Tracks and Analyzes Misfolded Protein Aggregation in Real Time

The accumulation of misfolded proteins in the brain is central to the progression of neurodegenerative diseases like Huntington’s, Alzheimer’s, and Parkinson’s. Yet to the human eye, proteins that are... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.